{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T11:02:18Z","timestamp":1789124538608,"version":"build-2803163510"},"reference-count":91,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T00:00:00Z","timestamp":1706140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Introduction: Depression is the most prevalent comorbid neuropsychiatric condition in individuals with Parkinson\u2019s disease (PD), and its underlying mechanisms are not yet fully understood. Current treatment methods are characterised by moderate effectiveness and possible side effects, prompting the search for new non-invasive and safe treatment methods. Methods: This narrative review explores the use of transcranial direct current stimulation (tDCS) in the treatment of depression in PD, based on neuropsychological measures. Searches were conducted in the PubMed\/Medline, Research Gate, and Cochrane databases. Results: Nine relevant studies were identified, where depression scores served as either primary or secondary outcomes. Stimulation protocols displayed heterogeneity, especially concerning choice of stimulation site. Patient samples were also heterogeneous. The majority of the studies incorporated anodal stimulation targeting the left dorsolateral prefrontal cortex (DLPFC). The results revealed a reduction in depression scores among PD patients following tDCS. Potential mechanisms through which tDCS may alleviate depression in PD were discussed and recommendations for future research were made. Conclusions: Preliminary evidence suggests that tDCS applied anodally to the left DLPFC reduces depression scores in people with PD; however, due to the heterogeneity of the studies analysed, the use of tDCS in this field should be approached with caution and warrants further validation and confirmation.<\/jats:p>","DOI":"10.3390\/jcm13030699","type":"journal-article","created":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T08:44:07Z","timestamp":1706172247000},"page":"699","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Effect of Transcranial Direct Current Stimulation (tDCS) on Depression in Parkinson\u2019s Disease\u2014A Narrative Review"],"prefix":"10.3390","volume":"13","author":[{"given":"James","family":"Chmiel","sequence":"first","affiliation":[{"name":"Institute of Neurofeedback and tDCS Poland, 70-393 Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"Rybakowski","sequence":"additional","affiliation":[{"name":"Department and Clinic of Psychiatry, Poznan University of Medical Sciences, 61-701 Pozna\u0144, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerzy","family":"Leszek","sequence":"additional","affiliation":[{"name":"Department and Clinic of Psychiatry, Wroc\u0142aw Medical University, 54-235 Wroc\u0142aw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,1,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","article-title":"Epidemiology of Parkinson\u2019s disease","volume":"124","author":"Tysnes","year":"2017","journal-title":"J. Neural Transm."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.tiv.2017.06.008","article-title":"Neurodegenerative signaling factors and mechanisms in Parkinson\u2019s pathology","volume":"43","author":"Goswami","year":"2017","journal-title":"Toxicol. In Vitro"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.lfs.2019.03.057","article-title":"Parkinson\u2019s disease: Mechanisms, translational models and management strategies","volume":"226","author":"Raza","year":"2019","journal-title":"Life Sci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1016\/j.parkreldis.2015.09.004","article-title":"Non-motor symptoms in Parkinson\u2019s disease","volume":"22","author":"Pfeiffer","year":"2016","journal-title":"Park. Relat. Disord."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neubiorev.2019.04.002","article-title":"Depression in neurodegenerative diseases: Common mechanisms and current treatment options","volume":"102","author":"Galts","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jns.2016.12.060","article-title":"Neuropsychiatric symptoms, behavioural disorders, and quality of life in Parkinson\u2019s disease","volume":"373","author":"Balestrino","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s40266-022-00942-1","article-title":"Depression in Patients with Parkinson\u2019s Disease: Current Understanding of its Neurobiology and Implications for Treatment","volume":"39","author":"Prange","year":"2022","journal-title":"Drugs Aging"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrneurol.2011.189","article-title":"Depression in Parkinson disease\u2014Epidemiology, mechanisms and management","volume":"8","author":"Aarsland","year":"2011","journal-title":"Nat. Rev. Neurol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"G\u00e1lvez-Jim\u00e9nez, N., Korczyn, A., and Lugo-Sanchez, R. (2022). Non-Motor Parkinson\u2019s Disease, Cambridge University Press.","DOI":"10.1017\/9781009039291"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e961372","DOI":"10.1155\/2015\/961372","article-title":"Qualitative characteristics of depression in Parkinson\u2019s patients and controls","volume":"2015","author":"Kritzinger","year":"2015","journal-title":"Behav. Neurol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/mds.870120607","article-title":"Symptoms and duration of the prodromal phase in Parkinson\u2019s disease","volume":"12","author":"Gonera","year":"1997","journal-title":"Mov. Disord."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/mds.26077","article-title":"The onset of nonmotor symptoms in Parkinson\u2019s disease (the ONSET PD study)","volume":"30","author":"Hotter","year":"2015","journal-title":"Mov. Disord."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1474-4422(14)70287-X","article-title":"Prediagnostic presentations of Parkinson\u2019s disease in primary care: A case-control study","volume":"14","author":"Schrag","year":"2015","journal-title":"Lancet Neurol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Cong, S., Xiang, C., Zhang, S., Zhang, T., Wang, H., and Cong, S. (2022). Prevalence and clinical aspects of depression in Parkinson\u2019s disease: A systematic review and meta-analysis of 129 studies. Neurosci. Biobehav. Rev., 141.","DOI":"10.1016\/j.neubiorev.2022.104749"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/0891988713481269","article-title":"Barriers to mental health care utilization in Parkinson\u2019s disease","volume":"26","author":"Dobkin","year":"2013","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1353-8020(01)00015-3","article-title":"Non-recognition of depression and other non-motor symptoms in Parkinson\u2019s disease","volume":"8","author":"Shulman","year":"2002","journal-title":"Park. Relat. Disord."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/mds.21803","article-title":"A systematic review of prevalence studies of depression in Parkinson\u2019s disease","volume":"23","author":"Reijnders","year":"2008","journal-title":"Mov. Disord."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1093\/brain\/awh445","article-title":"Depression in Parkinson\u2019s disease: Loss of dopamine and noradrenaline innervation in the limbic system","volume":"128","author":"Remy","year":"2005","journal-title":"Brain"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"101840","DOI":"10.1016\/j.arr.2022.101840","article-title":"Neurobiology of depression in Parkinson\u2019s disease: Insights into epidemiology, molecular mechanisms and treatment strategies","volume":"85","author":"Ahmad","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s11910-013-0409-5","article-title":"Depression and Parkinson\u2019s disease: Current knowledge","volume":"13","author":"Marsh","year":"2013","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1080\/14656566.2019.1612877","article-title":"Drug treatment strategies for depression in Parkinson disease","volume":"20","author":"Ryan","year":"2019","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/mds.21966","article-title":"Comparison of desipramine and citalopram treatments for depression in Parkinson\u2019s disease: A double-blind, randomized, placebo-controlled study","volume":"23","author":"Devos","year":"2008","journal-title":"Mov. Disord."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1212\/01.wnl.0000336340.89821.b3","article-title":"A controlled trial of antidepressants in patients with Parkinson disease and depression","volume":"72","author":"Menza","year":"2009","journal-title":"Neurology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1212\/WNL.0b013e3182516244","article-title":"A randomized, double-blind, placebo controlled trial of antidepressants in Parkinson disease","volume":"78","author":"Richard","year":"2012","journal-title":"Neurology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1017\/S1041610210001687","article-title":"Bupropion in the treatment of depression in Parkinson\u2019s disease","volume":"23","author":"Dyduch","year":"2011","journal-title":"Int. Psychogeriatr."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1176\/appi.ajp.2011.10111669","article-title":"Cognitive-behavioral therapy for depression in Parkinson\u2019s disease: A randomized, controlled trial","volume":"168","author":"Dobkin","year":"2011","journal-title":"Am. J. Psychiatry"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1002\/mds.27865","article-title":"Exercise increases caudate dopamine release and ventral striatal activation in Parkinson\u2019s disease","volume":"34","author":"Sacheli","year":"2019","journal-title":"Mov. Disord."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.brs.2008.06.004","article-title":"Transcranial direct current stimulation: State of the art 2008","volume":"1","author":"Nitsche","year":"2008","journal-title":"Brain Stimul."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1152\/jn.00608.2009","article-title":"Time course of the induction of homeostatic plasticity generated by repeated transcranial direct current stimulation of the human motor cortex","volume":"105","author":"Fricke","year":"2011","journal-title":"J. Neurophysiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/YCT.0000000000000510","article-title":"Physiology of transcranial direct current stimulation","volume":"34","author":"Stagg","year":"2018","journal-title":"J. ECT"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1469-7793.2000.t01-1-00633.x","article-title":"Excitability changes induced in the human motor cortex by weak transcranial direct current stimulation","volume":"527","author":"Nitsche","year":"2000","journal-title":"J. Physiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1113\/jphysiol.2003.049916","article-title":"Pharmacological modulation of cortical excitability shifts induced by transcranial direct current stimulation in humans","volume":"553","author":"Nitsche","year":"2003","journal-title":"J. Physiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.brs.2009.04.002","article-title":"Anodal skin lesions after treatment with transcranial direct current stimulation","volume":"3","author":"Frank","year":"2010","journal-title":"Brain Stimul."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40035-021-00245-2","article-title":"The effects of transcranial direct current stimulation on gait in patients with Parkinson\u2019s disease: A systematic review","volume":"10","author":"Pol","year":"2021","journal-title":"Transl. Neurodegener."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s10020-021-00284-5","article-title":"Modulating brain networks associated with cognitive deficits in Parkinson\u2019s disease","volume":"27","author":"Beheshti","year":"2021","journal-title":"Mol. Med."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Zaehle, T. (2021). Frontal Transcranial Direct Current Stimulation as a Potential Treatment of Parkinson\u2019s Disease-Related Fatigue. Brain Sci., 11.","DOI":"10.3390\/brainsci11040467"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.neulet.2016.11.019","article-title":"Can transcranial direct current stimulation on the dorsolateral prefrontal cortex improves balance and functional mobility in Parkinson\u2019s disease?","volume":"636","author":"Lattari","year":"2017","journal-title":"Neurosci. Lett."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"25","DOI":"10.5935\/1984-0063.20200083","article-title":"Melatonin serum level, sleep functions, and depression level after bilateral anodal transcranial direct current stimulation in patients with Parkinson\u2019s disease: A feasibility study","volume":"14","author":"Hadoush","year":"2021","journal-title":"Sleep Sci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"198","DOI":"10.12659\/MSMBR.911411","article-title":"Sleep Quality, Depression, and Quality of Life After Bilateral Anodal Transcranial Direct Current Stimulation in Patients with Parkinson\u2019s Disease","volume":"24","author":"Hadoush","year":"2018","journal-title":"Med. Sci. Monit. Basic. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1136\/jnnp.2009.202556","article-title":"Transcranial direct current stimulation for the treatment of Parkinson\u2019s disease","volume":"81","author":"Benninger","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"830976","DOI":"10.3389\/fneur.2022.830976","article-title":"Anodal Transcranial Direct Current Stimulation Could Modulate Cortical Excitability and the Central Cholinergic System in Akinetic Rigid Type Parkinson\u2019s Disease: Pilot Study","volume":"13","author":"Oh","year":"2022","journal-title":"Front. Neurol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s12311-015-0737-x","article-title":"Cerebellar and Motor Cortical Transcranial Stimulation Decrease Levodopa-Induced Dyskinesias in Parkinson\u2019s Disease","volume":"15","author":"Ferrucci","year":"2016","journal-title":"Cerebellum"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/mds.26561","article-title":"Mild cognitive impairment in Parkinson\u2019s disease is improved by transcranial direct current stimulation combined with physical therapy","volume":"31","author":"Manenti","year":"2016","journal-title":"Mov. Disord."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.brs.2018.07.046","article-title":"Transcranial direct current stimulation combined with cognitive training for the treatment of Parkinson Disease: A randomized, placebo controlled study","volume":"11","author":"Manenti","year":"2018","journal-title":"Brain Stimul."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neulet.2014.08.043","article-title":"Effects of tDCS on executive function in Parkinson\u2019s disease","volume":"582","author":"Doruk","year":"2014","journal-title":"Neurosci. Lett."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.brs.2015.07.043","article-title":"Double-blind Randomized Trial of tDCS Versus Sham in Parkinson Patients With Mild Cognitive Impairment Receiving Cognitive Training","volume":"8","author":"Biundo","year":"2015","journal-title":"Brain Stimul."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"114024","DOI":"10.1016\/j.psychres.2021.114024","article-title":"Follow-up effects of transcranial direct current stimulation (tDCS) for the major depressive episode: A systematic review and meta-analysis","volume":"302","author":"Razza","year":"2021","journal-title":"Psychiatry Res."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Wang, J., Luo, H., Sch\u00fclke, R., Geng, X., Sahakian, B.J., and Wang, S. (2021). Is transcranial direct current stimulation, alone or in combination with antidepressant medications or psychotherapies, effective in treating major depressive disorder? A systematic review and meta-analysis. BMC Med., 19.","DOI":"10.1186\/s12916-021-02181-4"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41386-021-01101-7","article-title":"Prefrontal cortex and depression","volume":"47","author":"Pizzagalli","year":"2022","journal-title":"Neuropsychopharmacology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/mp.2008.57","article-title":"Amygdala volume in major depressive disorder: A meta-analysis of magnetic resonance imaging studies","volume":"13","author":"Hamilton","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.biopsych.2011.06.006","article-title":"Depression and the hippocampus: Cause or effect?","volume":"70","author":"Sheline","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1007\/s00415-016-8241-x","article-title":"Cortical thinning in drug-naive Parkinson\u2019s disease patients with depression","volume":"263","author":"Luo","year":"2016","journal-title":"J. Neurol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.pnpbp.2012.05.016","article-title":"Transcranial direct current stimulation for the treatment of major depressive disorder: A summary of preclinical, clinical and translational findings","volume":"39","author":"Brunoni","year":"2012","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1038\/npp.2013.126","article-title":"Neuroplasticity in depressed individuals compared with healthy controls","volume":"38","author":"Player","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1080\/09540261.2021.1879030","article-title":"Is tDCS a potential first line treatment for major depression?","volume":"33","author":"Woodham","year":"2021","journal-title":"Int. Rev. Psychiatry"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jad.2014.05.063","article-title":"Increase in PAS-induced neuroplasticity after a treatment course of transcranial direct current stimulation for depression","volume":"167","author":"Player","year":"2014","journal-title":"J. Affect. Disord."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0165-1781(02)00005-7","article-title":"Decreased serum brain-derived neurotrophic factor levels in major depressed patients","volume":"109","author":"Karege","year":"2002","journal-title":"Psychiatry Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3389\/fncel.2019.00363","article-title":"Brain-derived neurotrophic factor: A key molecule for memory in the healthy and the pathological brain","volume":"13","author":"Miranda","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1007\/s00213-018-4950-4","article-title":"Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression","volume":"235","author":"Levy","year":"2018","journal-title":"Psychopharmacology"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.brainres.2018.10.006","article-title":"Plasma levels of brain-derived neurotrophic factor in patients with Parkinson disease: A systematic review and meta-analysis","volume":"1704","author":"Rahmani","year":"2019","journal-title":"Brain Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.parkreldis.2017.05.012","article-title":"Association of low serum BDNF with depression in patients with Parkinson\u2019s disease","volume":"41","author":"Wang","year":"2017","journal-title":"Park. Relat. Disord."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s00415-020-10299-3","article-title":"Serum BDNF discriminates Parkinson\u2019s disease patients with depression from without depression and reflect motor severity and gender differences","volume":"268","author":"Huang","year":"2021","journal-title":"J. Neurol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"100367","DOI":"10.1016\/j.ijchp.2023.100367","article-title":"Non-pharmacological treatment-related changes of molecular biomarkers in major depressive disorder: A systematic review and meta-analysis","volume":"23","author":"Irwin","year":"2023","journal-title":"Int. J. Clin. Health Psychol."},{"key":"ref_64","first-page":"85","article-title":"Transcranial Direct Current Stimulation Over the Prefrontal Cortex in Depression Modulates Cortical Excitability in Emotion Regulation Regions as Measured by Concurrent Functional Magnetic Resonance Imaging: An Exploratory Study","volume":"7","author":"Chrysikou","year":"2022","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.brainres.2014.09.066","article-title":"Baseline effects of transcranial direct current stimulation on glutamatergic neurotransmission and large-scale network connectivity","volume":"1594","author":"Hunter","year":"2015","journal-title":"Brain Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1093\/cercor\/bhy093","article-title":"Frontal transcranial direct current stimulation induces dopamine release in the ventral striatum in human","volume":"28","author":"Fonteneau","year":"2018","journal-title":"Cereb. Cortex"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41398-019-0443-4","article-title":"Endogenous dopamine release under transcranial direct-current stimulation governs enhanced attention: A study with positron emission tomography","volume":"9","author":"Fukai","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pscychresns.2005.12.004","article-title":"Review of 1H magnetic resonance spectroscopy findings in major depressive disorder: A meta-analysis","volume":"147","author":"Ankerst","year":"2006","journal-title":"Psychiatry Res. Neuroimaging"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.pharmthera.2005.11.006","article-title":"Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application","volume":"110","author":"Millan","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"886918","DOI":"10.3389\/fpsyt.2022.886918","article-title":"Glutamatergic System in Depression and Its Role in Neuromodulatory Techniques Optimization","volume":"13","author":"Khoodoruth","year":"2022","journal-title":"Front. Psychiatry"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"761348","DOI":"10.3389\/fnagi.2021.761348","article-title":"Impact of Transcranial Direct Current Stimulation and Cognitive Training on Frontal Lobe Neurotransmitter Concentrations","volume":"13","author":"Boutzoukas","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"13276","DOI":"10.1038\/s41598-018-31517-z","article-title":"Cerebrospinal fluid concentrations of inflammatory markers in Parkinson\u2019s disease and atypical parkinsonian disorders","volume":"8","author":"Hall","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.autrev.2016.07.022","article-title":"Parkinson\u2019s disease: Autoimmunity and neuroinflammation","volume":"15","author":"Greco","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","article-title":"Inflammation and immune dysfunction in Parkinson disease","volume":"22","author":"Tansey","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Tonhajzerova, I., Sekaninova, N., Bona Olexova, L., and Visnovcova, Z. (2020). Novel insight into neuroimmune regulatory mechanisms and biomarkers linking major depression and vascular diseases: The dilemma continues. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21072317"},{"key":"ref_76","first-page":"3853","article-title":"Relationship between levels of inflammatory cytokines in the peripheral blood and the severity of depression and anxiety in patients with Parkinson\u2019s disease","volume":"20","author":"Wang","year":"2016","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3389\/fnins.2020.00028","article-title":"Transcranial direct current stimulation ameliorates cognitive impairment via modulating oxidative stress, inflammation, and autophagy in a rat model of vascular dementia","volume":"14","author":"Guo","year":"2020","journal-title":"Front. Neurosci."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s00213-013-3322-3","article-title":"Cytokines plasma levels during antidepressant treatment with sertraline and transcranial direct current stimulation (tDCS): Results from a factorial, randomized, controlled trial","volume":"231","author":"Brunoni","year":"2014","journal-title":"Psychopharmacology"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.pnpbp.2018.06.003","article-title":"Plasma biomarkers in a placebo-controlled trial comparing tDCS and escitalopram efficacy in major depression","volume":"86","author":"Brunoni","year":"2018","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Goerigk, S., Cretaz, E., Sampaio-Junior, B., Vieira, \u00c9.L.M., Gattaz, W., Klein, I., Lafer, B., Teixeira, A.L., Carvalho, A.F., and Lotufo, P.A. (2021). Effects of tDCS on neuroplasticity and inflammatory biomarkers in bipolar depression: Results from a sham controlled study. Prog. Neuropsychopharmacol. Biol. Psychiatry, 105.","DOI":"10.1016\/j.pnpbp.2020.110119"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Miquel-Rio, L., Sarri\u00e9s-Serrano, U., Pavia-Collado, R., Meana, J.J., and Bortolozzi, A. (2023). The Role of \u03b1-Synuclein in the Regulation of Serotonin System: Physiological and Pathological Features. Biomedicines, 11.","DOI":"10.3390\/biomedicines11020541"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/s41593-019-0423-2","article-title":"Lewy pathology in Parkinson\u2019s disease consists of crowded organelles and lipid membranes","volume":"22","author":"Shahmoradian","year":"2019","journal-title":"Nat. Neurosci."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3389\/fneur.2018.00455","article-title":"On Cell Loss and Selective Vulnerability of Neuronal Populations in Parkinson\u2019s Disease","volume":"9","author":"Trudeau","year":"2018","journal-title":"Front. Neurol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0006-8993(90)90733-R","article-title":"Loss of brainstem serotonin- and substance P-containing neurons in Parkinson\u2019s disease","volume":"510","author":"Halliday","year":"1990","journal-title":"Brain Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"128ra41","DOI":"10.1126\/scitranslmed.3003391","article-title":"Serotonin neuron loss and nonmotor symptoms continue in Parkinson\u2019s patients treated with dopamine grafts","volume":"4","author":"Politis","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1038\/s41598-021-81693-8","article-title":"Direct current stimulation enhances neuronal alpha-synuclein degradation in vitro","volume":"11","author":"Sala","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"15165","DOI":"10.1038\/s41598-018-33515-7","article-title":"Anodal transcranial direct current stimulation prevents methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity by modulating autophagy in an in vivo mouse model of Parkinson\u2019s disease","volume":"8","author":"Lee","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1590\/0004-282x-anp-2020-0381","article-title":"Use of non-invasive stimulation in movement disorders: A critical review","volume":"79","author":"Godeiro","year":"2021","journal-title":"Arq. Neuropsiquiatr."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.clinph.2016.10.087","article-title":"Evidence-based guidelines on the therapeutic use of transcranial direct current stimulation (tDCS)","volume":"128","author":"Lefaucheur","year":"2017","journal-title":"Clin. Neurophysiol."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Lindqvist, D., Kaufman, E., Brundin, L., Hall, S., Surova, Y., and Hansson, O. (2012). Non-motor symptoms in patients with Parkinson\u2019s disease\u2014Correlations with inflammatory cytokines in serum. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0047387"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"6707","DOI":"10.1007\/s10072-022-06363-7","article-title":"Inflammatory markers and depression in Parkinson\u2019s disease: A systematic review","volume":"43","author":"Ramanzini","year":"2022","journal-title":"Neurol. Sci."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/3\/699\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:49:19Z","timestamp":1760104159000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/3\/699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,25]]},"references-count":91,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["jcm13030699"],"URL":"https:\/\/doi.org\/10.3390\/jcm13030699","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,25]]}}}